Unity Biotechnology, Inc. (UBX): Price and Financial Metrics
UBX Price/Volume Stats
| Current price | $0.96 | 52-week high | $2.02 |
| Prev. close | $0.97 | 52-week low | $0.95 |
| Day low | $0.95 | Volume | 121,000 |
| Day high | $1.00 | Avg. volume | 66,498 |
| 50-day MA | $1.24 | Dividend yield | N/A |
| 200-day MA | $1.43 | Market Cap | 16.17M |
UBX Stock Price Chart Interactive Chart >
Unity Biotechnology, Inc. (UBX) Company Bio
Unity Biotechnology, Inc., a preclinical biotechnology company, engages in the research and development of therapeutics to extend human health span. The company’s lead drug candidates include UBX0101 for musculoskeletal disease with an initial focus on osteoarthritis; and UBX1967 for ophthalmologic diseases. It is also developing programs in pulmonary disorders. The company was formerly known as Forge, Inc. and changed its name to Unity Biotechnology, Inc. in January 2015. Unity Biotechnology, Inc. was founded in 2009 and is based in Brisbane, California.
UBX Price Returns
| 1-mo | -17.24% |
| 3-mo | -33.79% |
| 6-mo | -31.67% |
| 1-year | -40.00% |
| 3-year | -93.77% |
| 5-year | -98.71% |
| YTD | -50.26% |
| 2023 | -29.56% |
| 2022 | -81.23% |
| 2021 | -72.14% |
| 2020 | -27.32% |
| 2019 | -55.66% |
Loading social stream, please wait...